462 related articles for article (PubMed ID: 24704332)
1. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes.
Chanda D; Kim DK; Li T; Kim YH; Koo SH; Lee CH; Chiang JY; Choi HS
J Biol Chem; 2011 Aug; 286(32):27971-9. PubMed ID: 21693703
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway.
Yu JW; Sun LJ; Liu W; Zhao YH; Kang P; Yan BZ
Int J Infect Dis; 2013 Jul; 17(7):e539-45. PubMed ID: 23510538
[TBL] [Abstract][Full Text] [Related]
4. Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMP-response element-binding protein H (Crebh)-mediated induction of Lipin1 gene.
Chanda D; Kim YH; Kim DK; Lee MW; Lee SY; Park TS; Koo SH; Lee CH; Choi HS
J Biol Chem; 2012 Nov; 287(45):38041-9. PubMed ID: 22989885
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents.
Shahidi M; Tay ESE; Read SA; Ramezani-Moghadam M; Chayama K; George J; Douglas MW
J Gen Virol; 2014 Nov; 95(Pt 11):2468-2479. PubMed ID: 25053565
[TBL] [Abstract][Full Text] [Related]
6. Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.
Qadri I; Choudhury M; Rahman SM; Knotts TA; Janssen RC; Schaack J; Iwahashi M; Puljak L; Simon FR; Kilic G; Fitz JG; Friedman JE
J Biol Chem; 2012 Oct; 287(44):37340-51. PubMed ID: 22955269
[TBL] [Abstract][Full Text] [Related]
7. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of silent information regulator 1 induces glucose metabolism disorders of hepatocytes and enhances hepatitis C virus replication.
Yu JW; Sun LJ; Zhao YH; Kang P; Yan BZ
Hepatol Int; 2013 Jun; 7(2):524-32. PubMed ID: 26201784
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.
Patsenker E; Sachse P; Chicca A; Gachet MS; Schneider V; Mattsson J; Lanz C; Worni M; de Gottardi A; Semmo M; Hampe J; Schafmayer C; Brenneisen R; Gertsch J; Stickel F; Semmo N
Int J Mol Sci; 2015 Mar; 16(4):7057-76. PubMed ID: 25826533
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of silent information regulator-1 in hepatocytes induces lipid metabolism disorders and enhances hepatitis C virus replication].
Sun LJ; Zhao YH; Li SC; Yu JW; Kang P; Liu W
Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):834-9. PubMed ID: 24331693
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.
Lee MY; Chen WC; Hsu WH; Chen SC; Lee JC
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540136
[TBL] [Abstract][Full Text] [Related]
12. Effects of cannabinoid receptors on skeletal muscle oxidative pathways.
Cavuoto P; McAinch AJ; Hatzinikolas G; Cameron-Smith D; Wittert GA
Mol Cell Endocrinol; 2007 Mar; 267(1-2):63-9. PubMed ID: 17270342
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity.
Ge Q; Maury E; Rycken L; Gérard J; Noël L; Detry R; Navez B; Brichard SM
Int J Obes (Lond); 2013 Jun; 37(6):874-80. PubMed ID: 22868830
[TBL] [Abstract][Full Text] [Related]
14. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
[TBL] [Abstract][Full Text] [Related]
15. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages.
Jiang LS; Pu J; Han ZH; Hu LH; He B
Cardiovasc Res; 2009 Mar; 81(4):805-13. PubMed ID: 19074161
[TBL] [Abstract][Full Text] [Related]
16. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
[TBL] [Abstract][Full Text] [Related]
17. Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model.
Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
Biochem Biophys Res Commun; 2015 May; 460(4):1063-8. PubMed ID: 25843798
[TBL] [Abstract][Full Text] [Related]
18. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor.
Pucci M; Pasquariello N; Battista N; Di Tommaso M; Rapino C; Fezza F; Zuccolo M; Jourdain R; Finazzi Agrò A; Breton L; Maccarrone M
J Biol Chem; 2012 May; 287(19):15466-78. PubMed ID: 22431736
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
